Company started their own manufacturing facilities in the year 1998 from Chilakamarri Village, Shadnagar, Mahboobnagar District, Andhra Pradesh with manufacturing of 2,4 Dichloro 5 Fluoro Acetophenone (DCFA). Company had started export of their products in the year 2002 to Israel followed by exports to other countries like Italy, Japan, France, USA and Singapore. Currently, exports comprise of 12.37% of total turnover.
They are engaged in manufacture of Basic & Advanced Intermediates and fine chemicals and are presently having manufacturing facilities for key intermediates like 2,4-Dichloro-5-Fluoro Acetophenone (DCFA) (an intermediate for synthesizing quinolone antibiotics like ciprofloxacin); Chlorohexanone (key intermediate in the manufacture of cardio vascular medicine) and Methyl-4 (4-Chloro 1 oxo butane) a, a Di-Methyl Acetate (an intermediate in the manufacture of Fexofenadine an anti allergic drug). DCFA have contributed 39.88% of our total sales whereas Methyl-4 (4-Chloro 1 oxo butane) a, a Di-Methyl Acetate contributed 18.30% and Chlorohexanone contributed 5.39% of the total sales during 2006- 07.
Objects of the Issue:
1. The objects of the Issue are to achieve the benefits of listing on the Stock Exchanges & to raise capital to: Setting up a new plant for manufacturing of drug intermediates including Active Pharmaceutical Ingredients (APIs);
2. Setting up of pilot plant for carrying out Contract Research and Manufacturing (CRAM);
3. Meeting long term working capital requirement;
4. Meeting general corporate purposes;
5. Meet the expenses of this Issue.
Anu’s Laboratories Limited IPO Information
»» Public Issue Open: May 12, 2008 to May 15, 2008
»» Public Issue Type: 100% Book Built Issue (Initial Public Offer IPO)
»» Public Issue Size: 38,20,000 Equity Shares of Rs. 10/-
»» Face Value: Rs. 10/-
»» Public Issue Price: Rs 200/- to Rs 210/-
»» Maximum Subscription Amount for Retail Investor: Rs 100,000/-
»» Listing: BSE, NSE
»» Lead Manager: Almondz Global Securities Ltd